Medicare Enrolled
Dr. Priya Rudolph, MD, PHD
Hematology & Oncology · Athens, GA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Rudolph from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Rudolph?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Rudolph
Dr. Priya Rudolph is a hematology & oncology specialist in Athens, GA, with 21 years of NPI registration. Based on federal Medicare data, Dr. Rudolph performed 1,766 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Rudolph received a total of $645,289 from 66 pharmaceutical and/or device companies across 742 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Rudolph is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 21 years of NPI registration
▲ Top 25% volume in GA
$645,289 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗1,766
Medicare services
Top 25% in GA for hematology & oncology
Not available
Unique patients (not deduplicated)
$50
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,536 | $46 | $213 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
73 | $72 | $314 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
57 | $60 | $317 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
48 | $100 | $484 |
| Bone marrow biopsy and aspiration A procedure to remove a small sample of bone marrow and liquid for laboratory testing. The sample is analyzed to help diagnose various medical conditions. |
39 | $57 | $530 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
13 | $111 | $422 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$645,289
Total received (2018-2024)
Avg $92,184/year across 7 years
Top 0% in GA for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
66
Companies
742
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$172,960
2023
$218,481
2022
$78,188
2021
$55,191
2020
$29,462
2019
$43,161
2018
$47,845
Payments by company (2024)
PFIZER INC.
$44,468
Daiichi Sankyo Inc.
$33,969
AstraZeneca Pharmaceuticals LP
$21,777
Gilead Sciences, Inc.
$21,191
PUMA BIOTECHNOLOGY, INC.
$7,443
E.R. Squibb & Sons, L.L.C.
$6,533
Lilly USA, LLC
$5,985
Stemline Therapeutics Inc.
$5,882
EMD Serono, Inc.
$5,346
Incyte Corporation
$5,310
Ipsen Biopharmaceuticals, Inc
$4,795
MorphoSys, US Inc.
$3,080
ABBVIE INC.
$2,505
BTG International, Inc.
$1,500
Celgene Corporation
$1,122
Janssen Scientific Affairs, LLC
$313
SOBI, INC
$216
Tempus AI, Inc
$189
Amgen Inc.
$180
GlaxoSmithKline, LLC.
$170
Takeda Pharmaceuticals U.S.A., Inc.
$165
Merck Sharp & Dohme LLC
$145
Adaptive Biotechnologies Corporation
$111
JAZZ PHARMACEUTICALS INC.
$93
Eisai Inc.
$79
Corcept Therapeutics
$70
Genentech USA, Inc.
$58
Janssen Biotech, Inc.
$40
Blueprint Medicines Corporation
$33
ARRAY BIOPHARMA INC
$32
Novartis Pharmaceuticals Corporation
$27
Bayer Healthcare Pharmaceuticals Inc.
$23
Genmab U.S., Inc.
$23
Agios Pharmaceuticals, Inc.
$18
Coherus Biosciences Inc.
$18
Regeneron Healthcare Solutions, Inc.
$17
PharmaEssentia USA Corporation
$16
Alexion Pharmaceuticals, Inc.
$14
Top 3 companies account for 57.9% of 2024 payments
All-time payments by company (2018-2024) ›
PFIZER INC.
$132,098
AstraZeneca Pharmaceuticals LP
$96,188
Daiichi Sankyo Inc.
$89,484
Gilead Sciences, Inc.
$51,246
Stemline Therapeutics Inc.
$49,728
PUMA BIOTECHNOLOGY, INC.
$34,786
Seagen Inc.
$29,024
Puma Biotechnology, Inc.
$21,354
E.R. Squibb & Sons, L.L.C.
$17,914
GlaxoSmithKline, LLC.
$11,840
Janssen Scientific Affairs, LLC
$10,952
Incyte Corporation
$7,900
Bayer HealthCare Pharmaceuticals Inc.
$7,794
Boehringer Ingelheim Pharmaceuticals, Inc.
$7,339
ABBVIE INC.
$7,070
Epizyme, Inc.,
$7,010
CTI BioPharma Corp.
$6,975
MorphoSys, US Inc.
$6,525
Lilly USA, LLC
$6,087
EMD Serono, Inc.
$5,896
Ipsen Biopharmaceuticals, Inc
$4,845
AMAG Pharmaceuticals, Inc.
$3,996
Mylan Institutional Inc.
$3,817
Celgene Corporation
$2,960
Heron Therapeutics, Inc.
$2,934
ADC Therapeutics America, Inc.
$2,000
ARRAY BIOPHARMA INC
$1,975
GENZYME CORPORATION
$1,736
Seattle Genetics, Inc.
$1,690
Karyopharm Therapeutics Inc.
$1,587
TG THERAPEUTICS, INC.
$1,526
BTG International, Inc.
$1,500
Blueprint Medicines Corporation
$1,215
Coherus Biosciences Inc.
$1,010
AbbVie, Inc.
$825
Novartis Pharmaceuticals Corporation
$636
Astellas Pharma US Inc
$500
Amgen Inc.
$408
Alexion Pharmaceuticals, Inc.
$275
Genentech, Inc.
$251
Janssen Biotech, Inc.
$247
SOBI, INC
$216
Takeda Pharmaceuticals U.S.A., Inc.
$203
Adaptive Biotechnologies Corporation
$199
Tempus AI, Inc
$189
Eisai Inc.
$185
Merck Sharp & Dohme LLC
$145
Exelixis Inc.
$124
Kite Pharma, Inc.
$114
JAZZ PHARMACEUTICALS INC.
$93
BeiGene USA, Inc.
$72
Corcept Therapeutics
$70
Clovis Oncology, Inc.
$62
Regeneron Healthcare Solutions, Inc.
$62
Pharmacyclics LLC, An AbbVie Company
$61
EUSA Pharma (US) LLC
$60
Genentech USA, Inc.
$58
ImmunoGen, Inc.
$47
Bayer Healthcare Pharmaceuticals Inc.
$40
Alnylam Pharmaceuticals Inc.
$36
PharmaEssentia USA Corporation
$30
Genmab U.S., Inc.
$23
Agios Pharmaceuticals, Inc.
$18
G1 Therapeutics, Inc.
$18
Mirati Therapeutics, Inc.
$15
Janssen Pharmaceuticals, Inc
$6
Top 3 companies account for 49.2% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · ALUNBRIG · AYVAKIT · Aliqopa · BALVERSA · BAVENCIO · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Blincyto · CALQUENCE · COSELA · CUVITRU · Columvi · DARZALEX · ELREXFIO · ELZONRIS · ENHERTU · EPKINLY · ERLEADA · Elahere · Enhertu · Epkinly · FERAHEME · Fabhalta · GILOTRIF · GIVLAARI · Halaven · IBRANCE · ICLUSIG · IMBRUVICA · IMDELLTRA (AMG 757) · IMFINZI · Itovebi · JAKAFI · JAYPIRCA · JEVTANA · KEYTRUDA · KISQALI · KISUNLA · KRAZATI · Korlym · LIBTAYO · LORBRENA · LYNPARZA · Lenvima · MEKINIST · MONJUVI · NERLYNX · NINLARO · Nubeqa · OJJAARA · OPDIVO · OPDUALAG · Ogivri · Onivyde · Orserdu · PEMAZYRE · PROMACTA · Phesgo · Pomalyst · REBLOZYL · RYBREVANT · Rituxan · Rubraca · SOLIRIS · SUSTOL · SYNAGIS · Soliris · Sylvant · TAFINLAR · TAGRISSO · TALZENNA · TECENTRIQ · TECVAYLI · TIVDAK · TUKYSA · Tepmetko · Trodelvy · Truqap · ULTOMIRIS · Udenyca · Ultomiris · VENCLEXTA · VERZENIO · VONJO · Vectibix · Vistogard · Vitrakvi · Vonjo · XARELTO · XGEVA · XOSPATA · XPOVIO · Xofigo · Yescarta · ZEPZELCA · Zydelig · clonoSEQ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematology & oncology specialists in nearby ZIP areas
10
County median income
$52,267
Nearest hospital to ZIP centroid (approximate)
ST MARY'S HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Rudolph is a clinical cardiology specialist, with above-average Medicare volume (top 25% in GA), with 21 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Rudolph experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Rudolph performed 1,536 office visit, established patient (20-29 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Rudolph receive payments from pharmaceutical companies?
Yes. Dr. Rudolph received a total of $645,289 from 66 companies across 742 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Rudolph's costs compare to other hematology & oncology specialists in Athens?
Dr. Rudolph's average Medicare payment per service is $50. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Rudolph) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Athens
Browse hematology & oncology specialists in Athens ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in GA
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in GA
Which GA hematology & oncology specialists receive the most from drug and device companies.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Daiichi Sankyo Inc. Payments to Doctors
See all physicians who received payments from Daiichi Sankyo Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology